Mouse models in non-alcoholic fatty liver disease and steatohepatitis research

International Journal of Experimental Pathology

Volumn 87, Issue 1, 2006, Pages 1-16

  Anstee, Quentin M ^a   Goldin, Robert D ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ICF of M at St Mary's ^*  (United Kingdom)

Author keywords

Animal; Diabetes; Leptin; Review; Steatohepatitis

Indexed keywords

ANTIESTROGEN; CHOLINE; CYTOKINE; ETOMOXIR; LEPTIN; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN; METHIONINE; TAMOXIFEN; TRIACYLGLYCEROL; FATTY ACID;

ADIPOSE TISSUE; CELL DEATH; DIABETES MELLITUS; DIET; DIETARY INTAKE; DISEASE COURSE; ENVIRONMENT; FATTY ACID OXIDATION; FATTY LIVER; GENE DISRUPTION; GENE MUTATION; HISTOLOGY; HORMONE DEFICIENCY; HORMONE RESISTANCE; INSULIN RESISTANCE; LIPID PEROXIDATION; LIPOGENESIS; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER MITOCHONDRION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; ANIMAL; ANIMAL MODEL; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT;

ADIPOSE TISSUE; ANIMALS; FATTY ACIDS; FATTY LIVER; LEPTIN; MICE; MICE, MUTANT STRAINS; MODELS, ANIMAL; TRIGLYCERIDES;

EID: 33644955272     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2006.00465.x     Document Type: Review

References (124)

1. Adinolfi L.E. Gambardella M. Andreana A. Tripodi M.F. Utili R. Ruggiero G. 2001 Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 1358 1364
2. Ahima R.S. Saper C.B. Flier J.S. Elmquist J.K. 2000 Leptin regulation of neuroendocrine systems Front Neuroendocrinol 21 263 307
3. Almind K. Doria A. Kahn C.R. 2001 Putting the genes for type II diabetes on the map NatMed 7 277 279
4. Angulo P. Lindor K.D. 2002 Treatment of non-alcoholic steatohepatitis Best PractResClinGastroenterol 16 797 810
5. Anstee Q.M. Wright M. Goldin R. et al. 2003 A Novel murine model of non-alcoholic steatohepatitis generated using a sensitised ENU mutagenesis screen Hepatology Supplement 1 469A.
6. Aoyama T. Peters J.M. Iritani N. et al. 1998 Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha) JBiolChem 273 5678 5684
7. Araya J. Rodrigo R. Videla L.A. et al. 2004 Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease ClinSci(Lond) 106 635 643
8. Berriot-Varoqueaux N. Aggerbeck L.P. Samson-Bouma M. Wetterau J.R. 2000 The role of the microsomal triglygeride transfer protein in abetalipoproteinemia AnnuRevNutr 20 663 697
9. Biddinger S.B. Almind K. Miyazaki M. Kokkotou E. Ntambi J.M. Kahn C.R. 2005 Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome Diabetes 54 1314 1323
10. Bleisch V.R. Mayer J. Dickie M.M. 1952 Familial diabetes mellitus in mice, associated with insulin resistance, obesity, and hyperplasia of the islands of langerhans AmJPathol 28 369 385
11. Bradbury M.W. Berk P.D. 2004 Lipid metabolism in hepatic steatosis ClinLiver Dis 8 639 671 xi
12. Brix A.E. Elgavish A. Nagy T.R. Gower B.A. Rhead W.J. Wood P.A. 2002 Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse MolGenetMetab 75 219 226
13. Browning J.D. Horton J.D. 2004 Molecular mediators of hepatic steatosis and liver injury JClinInvest 114 147 152
14. Brunt E.M. 2004 Nonalcoholic steatohepatitis SeminLiver Dis 24 3 20
15. Caldwell S.H. Oelsner D.H. Iezzoni J.C. Hespenheide E.E. Battle E.H. Driscoll C.J. 1999 Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 664 669
16. Carvalho E. Jansson P.A. Nagaev I. Wenthzel A.M. Smith U. 2001 Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin- stimulated glucose transport FASEB J 15 1101 1103
17. Chalasani N. Crabb D.W. Cummings O.W. et al. 2003 Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? AmJGastroenterol 98 2771 2776
18. Chavin K.D. Yang S. Lin H.Z. et al. 1999 Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion JBiolChem 274 5692 5700
19. Chawla R.K. Watson W.H. Eastin C.E. Lee E.Y. Schmidt J. McClain C.J. 1998 S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury AmJPhysiol 275 G125 G129
20. Chen H. Charlat O. Tartaglia L.A. et al. 1996 Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 84 491 495
21. Coburn C.T. Knapp F.F. Jr. Febbraio M. Beets A.L. Silverstein R.L. Abumrad N.A. 2000 Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice JBiolChem 275 32523 32529
22. Coleman D.L. 1973 Effects of parabiosis of obese with diabetes and normal mice Diabetologia 9 294 298
23. Coleman D.L. 1978 Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice Diabetologia 14 141 148
24. Collins S. Martin T.L. Surwit R.S. Robidoux J. 2004 Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics PhysiolBehav 81 243 248
25. Crespo J. Cayon A. Fernandez-Gil P. et al. 2001 Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 1158 1163
26. Day C.P. 2002 Pathogensis of steatohepatitis BestPractResClinGastroenterol 16 663 678
27. Day C.P. James O.F. 1998 Steatohepatitis: a tale of two 'hits'? Gastroenterology 114 842 845
28. Deng Q.G. She H. Cheng J.H. et al. 2005 Steatohepatitis induced by intragastric overfeeding in mice Hepatology 42 905 914
29. Dentin R. Girard J. Postic C. 2005 Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver Biochimie 87 81 86
30. Dragani T.A. (ed.) 1998 Human Polygenic Diseases: Animal Models Australia Harwood.
31. Edvardsson U. von Lowenhielm H.B. Panfilov O. Nystrom A.C. Nilsson F. Dahllof B. 2003 Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators Proteomics 3 468 478
32. Enriquez A. Leclercq I. Farrell G.C. Robertson G. 1999 Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats BiochemBiophysResCommun 255 300 306
33. Faggioni R. Fantuzzi G. Gabay C. et al. 1999 Leptin deficiency enhances sensitivity to endotoxin-induced lethality AmJPhysiol 276 R136 R142
34. Fantuzzi G. Faggioni R. 2000 Leptin in the regulation of immunity, inflammation, and hematopoiesis JLeukocBiol 68 437 446
35. Feldstein A.E. Canbay A. Guicciardi M.E. Higuchi H. Bronk S.F. Gores G.J. 2003 Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice JHepatol 39 978 983
36. Fletcher L.M. Bridle K.R. Crawford D.H. 2003 Effect of alcohol on iron storage diseases of the liver Best PractResClinGastroenterol 17 663 677
37. Friedman S.L. 2003 Liver fibrosis - from bench to bedside JHepatol 38 Suppl. 1 S38 S53
38. Friedman J.M. Leibel R.L. Siegel D.S. Walsh J. Bahary N. 1991 Molecular mapping of the mouse ob mutation Genomics 11 1054 1062
39. Gao D. Wei C. Chen L. Huang J. Yang S. Diehl A.M. 2004 Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease AmJPhysiolGastrointestLiver Physiol 287 G1070 G1077
40. George J. Pera N. Phung N. Leclercq I. Yun Hou J. Farrell G. 2003 Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis JHepatol 39 756 764
41. Ghilardi N. Ziegler S. Wiestner A. Stoffel R. Heim M.H. Skoda R.C. 1996 Defective STAT signaling by the leptin receptor in diabetic mice ProcNatlAcadSciUSA 93 6231 6235
42. Goudriaan J.R. Dahlmans V.E. Teusink B. et al. 2003 CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice JLipid Res 44 2270 2277
43. Grubb S.C. Churchill G.A. Bogue M.A. 2004 A collaborative database of inbred mouse strain characteristics Bioinformatics 20 2857 2859
44. Guebre-Xabier M. Yang S. Lin H.Z. Schwenk R. Krzych U. Diehl A.M. 2000 Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage Hepatology 31 633 640
45. Honda H. Ikejima K. Hirose M. et al. 2002 Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver Hepatology 36 12 21
46. Hourigan L.F. Macdonald G.A. Purdie D. et al. 1999 Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1215 1219
47. Hu K.Q. Kyulo N.L. Esrailian E. et al. 2004 Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States JHepatol 40 147 154
48. Hummel K.P. Dickie M.M. Coleman D.L. 1966 Diabetes, a new mutation in the mouse Science 153 1127 1128
49. Ibdah J.A. Paul H. Zhao Y. et al. 2001 Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death JClinInvest 107 1403 1409
50. Ibdah J.A. Perlegas P. Zhao Y. et al. 2005 Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance Gastroenterology 128 1381 1390
51. Iizuka K. Bruick R.K. Liang G. Horton J.D. Uyeda K. 2004 Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis ProcNatlAcadSciUSA 101 7281 7286
52. Ingalls A.M. Dickie M.M. Snell G.D. 1950 Obese, a new mutation in the house mouse JHered 41 317 318
53. Jones D.E. 2005 Fat is an immuno-regulatory issue Hepatology 42 755 758
54. Kahn C.R. 1994 Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes Diabetes 43 1066 1084
55. Kashireddy P.V. Rao M.S. 2004 Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis HepatolRes 30 104 110
56. Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvergne B. Wahli W. 1999 Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting JClinInvest 103 1489 1498
57. Kirsch R. Clarkson V. Shephard E.G. et al. 2003 Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies JGastroenterolHepatol 18 1272 1282
58. Kleiner D.E. Brunt E.M. Van Natta M. et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 1321
59. Koppe S.W. Sahai A. Malladi P. Whitington P.F. Green R.M. 2004 Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet JHepatol 41 592 598
60. Koteish A. Diehl A.M. 2001 Animal models of steatosis SeminLiver Dis 21 89 104
61. Koteish A. Mae D.A. 2002 Animal models of steatohepatitis BestPractResClinGastroenterol 16 679 690
62. Kugelmas M. Hill D.B. Vivian B. Marsano L. Mcclain C.J. 2003 Cytokines and Nash: a pilot study of the effects of lifestyle modification and vitamin E Hepatology 38 413 419
63. Kulinski A. Vance D.E. Vance J.E. 2004 A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion JBiolChem 279 23916 23924
64. Kuwajima M. Kono N. Horiuchi M. et al. 1991 Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis BiochemBiophysResCommun 174 1090 1094
65. Leclercq I.A. Farrell G.C. Schriemer R. Robertson G.R. 2002 Leptin is essential for the hepatic fibrogenic response to chronic liver injury JHepatol 37 206 213
66. Leclercq I.A. Field J. Farrell G.C. 2003 Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury Gastroenterology 124 1451 1464
67. Letteron P. Sutton A. Mansouri A. Fromenty B. Pessayre D. 2003 Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice Hepatology 38 133 140
68. Li Z. Oben J.A. Yang S. et al. 2004 Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis Hepatology 40 434 441
69. Li Z. Soloski M.J. Diehl A.M. 2005 Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease Hepatology 42 880 885
70. Ludwig J. Viggiano T.R. Mcgill D.B. Oh B.J. 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo ClinProc 55 434 438
71. Marchesini G. Brizi M. Morselli-Labate A.M. et al. 1999 Association of nonalcoholic fatty liver disease with insulin resistance AmJMed 107 450 455
72. Marchesini G. Bugianesi E. Forlani G. et al. 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 917 923
73. Matteoni C.A. Younossi Z.M. Gramlich T. Boparai N. Liu Y.C. McCullough A.J. 1999 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1413 1419
74. Mayer J. Bates M.W. Dickie M.M. 1951 Hereditary diabetes in genetically obese mice Science 113 746 747
75. Mayer J. Dickie M.M. Bates M.W. Vitale J.J. 1951 Free selection of nutrients by hereditarily obese mice Science 113 745 746
76. McClain C.J. Mokshagundam S.P. Barve S.S. et al. 2004 Mechanisms of non-alcoholic steatohepatitis Alcohol 34 67 79
77. Mcgarry J.D. 2002 Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 51 7 18
78. Mcgarry J.D. Mannaerts G.P. Foster D.W. 1977 A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis JClinInvest 60 265 270
79. Memon R.A. Feingold K.R. Moser A.H. Fuller J. Grunfeld C. 1998 Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines AmJPhysiol 274 E210 E217
80. Oben J.A. Roskams T. Yang S. et al. 2003 Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice BiochemBiophysResCommun 308 284 292
81. Pessayre D. Berson A. Fromenty B. Mansouri A. 2001 Mitochondria in steatohepatitis SeminLiver Dis 21 57 69
82. Pessayre D. Mansouri A. Fromenty B. 2002 Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis AmJPhysiolGastrointestLiver Physiol 282 G193 G199
83. Poonawala A. Nair S.P. Thuluvath P.J. 2000 Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 689 692
84. Powell E.E. Cooksley W.G. Hanson R. Searle J. Halliday J.W. Powell L.W. 1990 The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 74 80
85. Poynard T. Bedossa P. Opolon P. 1997 Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 825 832
86. Rao M.S. Reddy J.K. 2001 Peroxisomal beta-oxidation and steatohepatitis SeminLiver Dis 21 43 55
87. Ratziu V. Giral P. Charlotte F. et al. 2000 Liver fibrosis in overweight patients Gastroenterology 118 1117 1123
88. Reddy J.K. 2001 Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis AmJPhysiolGastrointestLiver Physiol 281 G1333 G1339
89. Reeves H.L. Burt A.D. Wood S. Day C.P. 1996 Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis JHepatol 25 677 683
90. Reid A.E. 2001 Nonalcoholic steatohepatitis Gastroenterology 121 710 723
91. Rinella M.E. Green R.M. 2004 The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance JHepatol 40 47 51
92. Sahai A. Malladi P. Green R.M. Whitington P.F. 2003 Steatohepatitis and liver fibrosis associated with upregulated osteopontin expression in diabetic/insulin-resistant db/db mice fed a methionine and choline deficient diet Hepatology 38 497A
93. Sanyal A.J. 2002 AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 1705 1725
94. Sanyal A.J. Campbell-Sargent C. Mirshahi F. et al. 2001 Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 1183 1192
95. Schattenberg J.M. Wang Y. Singh R. Rigoli R.M. Czaja M.J. 2005 Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling JBiolChem 280 9887 9894
96. Shimano H. Horton J.D. Hammer R.E. Shimomura I. Brown M.S. Goldstein J.L. 1996 Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a JClinInvest 98 1575 1584
97. Shimomura I. Bashmakov Y. Horton J.D. 1999 Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus JBiolChem 274 30028 30032
98. Shimomura I. Hammer R.E. Richardson J.A. et al. 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy Genes Dev 12 3182 3194
99. Shimomura I. Shimano H. Korn B.S. Bashmakov Y. Horton J.D. 1998 Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver JBiolChem 273 35299 35306
100. Shoelson S.E. Lee J. Yuan M. 2003 Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int JObesRelat Metab Disord 27 Suppl. 3 S49 S52
101. Silver L.M. 1995 Mouse Genetics: Concepts and Applications New York, Oxford Oxford University Press.
102. Skelly M.M. James P.D. Ryder S.D. 2001 Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology JHepatol 35 195 199
103. Sundaram S.S. Whitington P.F. Green R.M. 2005 Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline- deficient diet AmJPhysiolGastrointestLiver Physiol 288 G1321 G1327
104. Tartaglia L.A. Dembski M. Weng X. et al. 1995 Identification and expression cloning of a leptin receptor, OB-R Cell 83 1263 1271
105. Teli M.R. Day C.P. Burt A.D. Bennett M.K. James O.F. 1995 Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 987 990
106. Tilg H. Diehl A.M. 2000 Cytokines in alcoholic and nonalcoholic steatohepatitis NEnglJMed 343 1467 1476
107. Tous M. Ferre N. Camps J. Riu F. Joven J. 2005 Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis MolCell Biochem 268 53 58
108. Toye A.A. Lippiat J.D. Proks P. et al. 2005 A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice Diabetologia 48 675 686
109. Uysal K.T. Wiesbrock S.M. Marino M.W. Hotamisligil G.S. 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 610 614
110. Voshol P.J. Haemmerle G. Ouwens D.M. et al. 2003 Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice Endocrinology 144 3456 3462
111. Voshol P.J. Jong M.C. Dahlmans V.E. et al. 2001 In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake Diabetes 50 2585 2590
112. Wanless I.R. Lentz J.S. 1990 Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1106 1110
113. Weltman M.D. Farrell G.C. Hall P. Ingelman-Sundberg M. Liddle C. 1998 Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Hepatology 27 128 133
114. Weltman M.D. Farrell G.C. Liddle C. 1996 Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation Gastroenterology 111 1645 1653
115. West D.B. Boozer C.N. Moody D.L. Atkinson R.L. 1992 Dietary obesity in nine inbred mouse strains AmJPhysiol 262 R1025 R1032
116. Wetterau J.R. Aggerbeck L.P. Bouma M.E. et al. 1992 Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia Science 258 999 1001
117. Winzell M.S. Ahren B. 2004 The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes Diabetes 53 Suppl. 3 S215 S219
118. Yamashita H. Takenoshita M. Sakurai M. et al. 2001 A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver ProcNatlAcadSciUSA 98 9116 9121
119. Yang S.Q. Lin H.Z. Lane M.D. Clemens M. Diehl A.M. 1997 Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis ProcNatlAcadSciUSA 94 2557 2562
120. Yao Z.M. Vance D.E. 1990 Reduction in VLDL, but not HDL, in plasma of rats deficient in choline BiochemCell Biol 68 552 558
121. Yoshimatsu M. Terasaki Y. Sakashita N. et al. 2004 Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process IntJExpPathol 85 335 343
122. Yuan M. Konstantopoulos N. Lee J. et al. 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 1673 1677
123. Zeisel S.H. Blusztajn J.K. 1994 Choline and human nutrition AnnuRevNutr 14 269 296
124. Zhang Y. Proenca R. Maffei M. Barone M. Leopold L. Friedman J.M. 1994 Positional cloning of the mouse obese gene and its human homologue Nature 372 425 432